Table 1.

Patient Characteristics at Baseline

CharacteristicAAQ + PQ (n = 167)DHP + PQ (n = 164)
Geometric mean of asexual Plasmodium vivax/µL (95% CI)1061 (876–1285)981 (811–1187)
Patients with gametocytes on admission67 (40.1)74 (45.1)
Sex
 Female66 (39.5)79 (48.2)
 Male101 (60.5)85 (51.8)
Weight, kg, median (range)38 (9–99)37 (10–80)
Age, y, median (range)13 (2–63)14.5 (2–70)
Age group
 <18 y106 (64.2)96 (59.3)
 ≥18 y59 (35.8)66 (40.8)
Temperature, mean (SD)37.7 (1.0)37.7 (1.0)
 ≥37.5°C, No. (%)92 (55.1)96 (58.5)
 <37.5°C, No. (%)75 (44.9)68 (41.5)
Hemoglobin concentration (mean, SD)12 (1.5)11.7 (1.4)
 ≥10 g/dL, No. (%)151 (90.4)148 (90.2)
 <10 g/dL, No. (%)16 (9.6)16 (9.8)
Methemoglobin concentration, mean (SD)1.63 (0.82)1.59 (0.95)
Repellent use38 (29.7)39 (32.7)
Insecticide-treated net use96 (60.4)105 (67.7)
History of antimalarial use28 (20)22 (15.9)
Occupation
 Unemployed20 (12.1)19 (11.8)
 Fisherman56 (33.9)52 (32.3)
 Laborer27 (16.4)31 (19.2)
 Housewife8 (4.9)7 (4.3)
 Businessman9 (5.4)6 (3.7)
 Teacher4 (2.4)4 (2.5)
 Student26 (15.8)26 (16.1)
 Policeman3 (1.8)3 (1.8)
 Farmer12 (7.3)13 (8.1)
Education
 Primary1 (0.8)3 (2.4)
 Junior high70 (53.4)61 (48.4)
 Senior high27 (20.6)29 (23.0)
 University29 (22.1)23 (18.2)
 No education4 (3.1)10 (7.9)
CharacteristicAAQ + PQ (n = 167)DHP + PQ (n = 164)
Geometric mean of asexual Plasmodium vivax/µL (95% CI)1061 (876–1285)981 (811–1187)
Patients with gametocytes on admission67 (40.1)74 (45.1)
Sex
 Female66 (39.5)79 (48.2)
 Male101 (60.5)85 (51.8)
Weight, kg, median (range)38 (9–99)37 (10–80)
Age, y, median (range)13 (2–63)14.5 (2–70)
Age group
 <18 y106 (64.2)96 (59.3)
 ≥18 y59 (35.8)66 (40.8)
Temperature, mean (SD)37.7 (1.0)37.7 (1.0)
 ≥37.5°C, No. (%)92 (55.1)96 (58.5)
 <37.5°C, No. (%)75 (44.9)68 (41.5)
Hemoglobin concentration (mean, SD)12 (1.5)11.7 (1.4)
 ≥10 g/dL, No. (%)151 (90.4)148 (90.2)
 <10 g/dL, No. (%)16 (9.6)16 (9.8)
Methemoglobin concentration, mean (SD)1.63 (0.82)1.59 (0.95)
Repellent use38 (29.7)39 (32.7)
Insecticide-treated net use96 (60.4)105 (67.7)
History of antimalarial use28 (20)22 (15.9)
Occupation
 Unemployed20 (12.1)19 (11.8)
 Fisherman56 (33.9)52 (32.3)
 Laborer27 (16.4)31 (19.2)
 Housewife8 (4.9)7 (4.3)
 Businessman9 (5.4)6 (3.7)
 Teacher4 (2.4)4 (2.5)
 Student26 (15.8)26 (16.1)
 Policeman3 (1.8)3 (1.8)
 Farmer12 (7.3)13 (8.1)
Education
 Primary1 (0.8)3 (2.4)
 Junior high70 (53.4)61 (48.4)
 Senior high27 (20.6)29 (23.0)
 University29 (22.1)23 (18.2)
 No education4 (3.1)10 (7.9)

Data are presented as No. (%) unless otherwise indicated.

Abbreviations: AAQ, artesunate-amodiaquine; CI, confidence interval; DHP, dihydroartemisinin-piperaquine; PQ, primaquine.

Table 1.

Patient Characteristics at Baseline

CharacteristicAAQ + PQ (n = 167)DHP + PQ (n = 164)
Geometric mean of asexual Plasmodium vivax/µL (95% CI)1061 (876–1285)981 (811–1187)
Patients with gametocytes on admission67 (40.1)74 (45.1)
Sex
 Female66 (39.5)79 (48.2)
 Male101 (60.5)85 (51.8)
Weight, kg, median (range)38 (9–99)37 (10–80)
Age, y, median (range)13 (2–63)14.5 (2–70)
Age group
 <18 y106 (64.2)96 (59.3)
 ≥18 y59 (35.8)66 (40.8)
Temperature, mean (SD)37.7 (1.0)37.7 (1.0)
 ≥37.5°C, No. (%)92 (55.1)96 (58.5)
 <37.5°C, No. (%)75 (44.9)68 (41.5)
Hemoglobin concentration (mean, SD)12 (1.5)11.7 (1.4)
 ≥10 g/dL, No. (%)151 (90.4)148 (90.2)
 <10 g/dL, No. (%)16 (9.6)16 (9.8)
Methemoglobin concentration, mean (SD)1.63 (0.82)1.59 (0.95)
Repellent use38 (29.7)39 (32.7)
Insecticide-treated net use96 (60.4)105 (67.7)
History of antimalarial use28 (20)22 (15.9)
Occupation
 Unemployed20 (12.1)19 (11.8)
 Fisherman56 (33.9)52 (32.3)
 Laborer27 (16.4)31 (19.2)
 Housewife8 (4.9)7 (4.3)
 Businessman9 (5.4)6 (3.7)
 Teacher4 (2.4)4 (2.5)
 Student26 (15.8)26 (16.1)
 Policeman3 (1.8)3 (1.8)
 Farmer12 (7.3)13 (8.1)
Education
 Primary1 (0.8)3 (2.4)
 Junior high70 (53.4)61 (48.4)
 Senior high27 (20.6)29 (23.0)
 University29 (22.1)23 (18.2)
 No education4 (3.1)10 (7.9)
CharacteristicAAQ + PQ (n = 167)DHP + PQ (n = 164)
Geometric mean of asexual Plasmodium vivax/µL (95% CI)1061 (876–1285)981 (811–1187)
Patients with gametocytes on admission67 (40.1)74 (45.1)
Sex
 Female66 (39.5)79 (48.2)
 Male101 (60.5)85 (51.8)
Weight, kg, median (range)38 (9–99)37 (10–80)
Age, y, median (range)13 (2–63)14.5 (2–70)
Age group
 <18 y106 (64.2)96 (59.3)
 ≥18 y59 (35.8)66 (40.8)
Temperature, mean (SD)37.7 (1.0)37.7 (1.0)
 ≥37.5°C, No. (%)92 (55.1)96 (58.5)
 <37.5°C, No. (%)75 (44.9)68 (41.5)
Hemoglobin concentration (mean, SD)12 (1.5)11.7 (1.4)
 ≥10 g/dL, No. (%)151 (90.4)148 (90.2)
 <10 g/dL, No. (%)16 (9.6)16 (9.8)
Methemoglobin concentration, mean (SD)1.63 (0.82)1.59 (0.95)
Repellent use38 (29.7)39 (32.7)
Insecticide-treated net use96 (60.4)105 (67.7)
History of antimalarial use28 (20)22 (15.9)
Occupation
 Unemployed20 (12.1)19 (11.8)
 Fisherman56 (33.9)52 (32.3)
 Laborer27 (16.4)31 (19.2)
 Housewife8 (4.9)7 (4.3)
 Businessman9 (5.4)6 (3.7)
 Teacher4 (2.4)4 (2.5)
 Student26 (15.8)26 (16.1)
 Policeman3 (1.8)3 (1.8)
 Farmer12 (7.3)13 (8.1)
Education
 Primary1 (0.8)3 (2.4)
 Junior high70 (53.4)61 (48.4)
 Senior high27 (20.6)29 (23.0)
 University29 (22.1)23 (18.2)
 No education4 (3.1)10 (7.9)

Data are presented as No. (%) unless otherwise indicated.

Abbreviations: AAQ, artesunate-amodiaquine; CI, confidence interval; DHP, dihydroartemisinin-piperaquine; PQ, primaquine.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close